Altmetrics
Downloads
81
Views
39
Comments
0
A peer-reviewed article of this preprint also exists.
supplementary.docx (18.84KB )
This version is not peer-reviewed
Submitted:
29 December 2023
Posted:
04 January 2024
You are already at the latest version
Myb subfamily | Groups | Number of members |
1R-MYB | SHAQKYF (CCA1-like ) | 9 |
Bdp1-like | 4 | |
TRF-like | 2 | |
Ada2-like (Transcriptional adapter putative-Ada2) | 2 | |
Myb-related | 1 | |
Zuotin-like | 1 | |
2R-MYB | Myb transcription factors | 13 |
Trichome differentiation protein GL1 related | 6 | |
Werewolf transcription factors related | 3 | |
Hypothetical proteins | 3 | |
R2R3-Myb transcription factors | 2 | |
4R-MYB | Snap190 | 1 |
Total | 47 |
1R-MYBS | ||||||||||
Group | Gene ID |
Gene (pb) |
mRNA |
Protein name | DBD-MYB | InterProScan domains | CD-Search domains |
H. sapiens c-Myb |
A. thaliana | E. histolytica |
TRF-like |
EIN_023650 |
1290 | 1290 |
EiTRF-like I |
348-392 |
Telomeric Repeat Binding Factor 1// TM Helix |
SANT_TRF/SANT Superfamily |
29.07% 7e-12 29.90% 3e-17 (TERF1) |
48.08% 3e-13 (CAD531509.1) |
49.89% 5e-133 (EHI_148140) |
EIN_079420 |
1404 | 1404 |
EiTRF-like II |
378-422 |
Telomeric Repeat Binding Factor 1// TM Helix |
SANT_TRF/SANT Superfamily |
26.32% 4e-14 35.87 8e-17 (TERF1) |
21.54% 2e-15 (OAP03200.1) |
55.13% 5e-164 (EHI_001110) |
|
CCA-like (SHAQKYF) | EIN_086260 |
540 |
540 |
EiMybS1 |
48-92 |
Myb-DNA Binding/SANT Superfamily | Myb-DNA Binding/SANT Superfamily/RSC8 Chromatin remodeling | 22.95% 4e-14 |
64.71% 6e-25 (AAF23291.1) |
63.10% 2e-45 (EHI_092160) |
EIN_087120 |
537 |
537 |
EiMybS2 |
46-90 |
Myb-DNA Binding/SANT Superfamily | Myb-DNA Binding/SANT Superfamily | 21.92% 1e-14 |
45.37% 6e-22 (AAF81310.1) |
52.43% 2e-35 (EHI_092160) |
|
EIN_031250* |
601 |
534 |
EiMybS3 |
41-85 |
Myb-DNA Binding/SANT Superfamily | Myb-DNA Binding/SANT Superfamily | 25.45% 2e-14 |
58.06% 6e-20 (OAP07468.1) |
54.55% 4e-35 (EHI_136420) |
|
EIN_095950 |
519 |
519 |
EiMybS4 |
83-133 |
Myb-DNA Binding/SANT Superfamily | SANT Superfamily |
16.13% 1e-11 |
20.83% 3e-12 (CAA0383923.1) |
38.22% 1e-18 (EHI_155580) |
|
EIN_224050 |
516 |
516 |
EiMybS5 |
83-133 |
Myb-DNA Binding/SANT Superfamily | SANT Superfamily |
25.64% 2e-09 |
27.78% 7e-12 (NP_00107786.1) |
39.10% 6e-17 (EHI_155580) |
|
EIN_020720 |
438 |
438 |
EiMybS6 |
56-106 |
Myb-DNA Binding/SANT Superfamily | SANT Superfamily |
- |
24.29% 2e-12 (CAA0367555.1) |
62.02% 5e-36 (EHI_051440) |
|
EIN_469690 |
399 |
399 |
EiMybS7 |
41-91 |
Myb-DNA Binding/SANT Superfamily | SANT Superfamily |
- |
21.51% 4e-16 (AAM63125.1) |
59.84% 5e-38 (EHI_051440) |
|
EIN_081930 |
408 |
408 |
EiMybS8 |
45-95 |
Myb-DNA Binding/SANT Superfamily | SANT Superfamily |
- |
29.63% 5e-14 (CAA0198797.1) |
51.88% 1e-33 (EHI_013340) |
|
EIN_407300 |
546 |
546 |
EiMybS9 |
88-138 |
Myb-DNA Binding/SANT Superfamily | SANT Superfamily |
23.64 % 3e-11 |
19.77% 5e-12 (NP_001330337.1) |
46.92% 6e-19 (EHI_038640) |
|
Ada2-like | EIN_359680* |
1229 |
993 |
EiAda2-Like 1 |
66-108 |
ADA2-like ZZ |
Histone acetyltransferase complex SAGA/ADA, subunit ADA2 [Chromatin structure and dynamics] | 18.75% 3e-13 |
30.59% 1e-62 (CAD5328117.1) |
64.85% 9e-146 (EHI_142140) |
EIN_390470 |
1032 |
1032 |
EiAda2-like 2 |
74-116 |
ADA2-like ZZ |
Histone acetyltransferase complex SAGA/ADA, subunit ADA2 [Chromatin structure and dynamics] | 20.83% 1e-09 |
34.38% 2e-60 (CAD5328118.1) |
46.86% 9e-92 (EHI_142140) |
|
Myb-related | EIN_020090 |
423 |
423 |
EiMyb-related 1 |
47-91 |
Myb-DNA Binding/SANT Superfamily | Myb-DNA Binding/SANT Superfamily | 29.1% 4e-17 |
32% 4e-18 (NP_201038.1) |
25.00% 6e-19 (EHI_009930) |
Zuotin |
EIN_182440* |
1658 |
1596 |
EiZuotin-like |
472-521 |
DNAJ domain |
ZUO1 Superfamily / SANT Superfamily | 16.26% 2e-21 |
30.24% 2e-29 (AAG51437.1) |
52.35% 8e-62 (EHI_128200) |
Bdp1-like |
EIN_223710 |
366 | 366 | EiBdp1-like 1 |
45-111 |
Transcription factor TFIIIB component B’, Myb domain |
SANT/Myb-like DNA-binding domain-containing protein |
- 28.95% 0.017 TFIIIB |
31.58% 8e-05 (CAB43631.1) |
34.29% 2e-10 (EHI_074810) |
EIN_034860 |
363 | 363 |
EiBdp1-like 2 |
48-110 |
Transcription factor TFIIIB component B'', Myb domain |
SANT/Myb-like DNA-binding domain-containing protein |
- 30.88% 5e-20 TFIIIB |
25.69% 4e-20 (CAD5330371.1) |
ND |
|
EIN_314460 |
522 | 522 |
EiBdp1-like 3 |
84-126 |
Transcription factor TFIIIB component B'', Myb domain |
SANT/Myb-like DNA-binding domain-containing protein |
17.65% 6e-15 |
23.70% 5e-20 (CAD5330371.1) |
65.68% 3e-37 (EHI_009820) |
|
EIN_096130 | 312 | 312 | EiBdp1-like 4 | 30-90 | Transcription factor TFIIIB component B'', Myb domain | BDP1 super family | - | 30.77% 3e-06 (CAB43631.1) |
40.59% 3e-12 (EHI_009820) |
|
2R-MYBS | ||||||||||
I |
EIN_284910 |
519 |
519 |
EiMyb1 |
28-121 |
Myb-DNA Binding/SANT Superfamily |
Transcription repressor MYB5; Provisional |
33.63% 6e-44 |
34.35% 1e-42 (NP_001330339.1) |
42.55% 2e-43 (EHI_063550) |
EIN_178740 |
531 |
531 |
EiMyb2 |
26-119 |
Myb-DNA Binding/SANT Superfamily |
Transcription repressor MYB5; Provisional |
30.89% 4e-46 |
33.33% 1e-43 (NP_190575.1) |
42.25% 1e-39 (EHI_063550) |
|
- |
EIN_047330 |
474 |
474 |
EiMyb3 |
18-112 |
Myb-DNA Binding/SANT Superfamily |
SANT DNA binding domain / Transcription repressor MYB5; Provisional |
38.39% 2e-40 |
31.45% 2e-42 (NP_190575.1) |
35.26% 1e-41 (EHI_063550) |
II |
EIN_206260 |
450 |
450 |
EiMyb4 |
16-110 |
Myb-DNA Binding/SANT Superfamily |
PLN03091 super family hypothetical protein; Provisional | 34.17% 6e-45 |
35.42% 1e-45 (NP_190575.1) |
34.09% 6e-41 (EHI_063550) |
EIN_169560 |
438 |
438 |
EiMyb5 |
14-109 |
Myb-DNA Binding/SANT Superfamily |
REB1 superfamily |
25.19% 1e-44 |
37.93% 5e-43 (NP_190575.1) |
37.40% 1e-37 (EHI_063550) |
|
EIN_168610 |
447 |
447 |
EiMyb6 |
16-110 |
Myb-DNA Binding/SANT Superfamily |
PLN03091 super family hypothetical protein; Provisional |
27.83% 1e-42 |
37.93% 5e-43 (NP_190575.1) |
39.69% 1e-37 (EHI_098070) |
|
EIN_207200 |
447 |
447 |
EiMyb7 |
17-79 |
Myb-DNA Binding/SANT Superfamily |
REB1 superfamily |
29.29% 4e-45 |
36.36% 1e-44 (NP_190575.1) |
42.34% 5e-41 (EHI_098070) |
|
EIN_022390 |
495 |
495 |
EiMyb8 |
29-122 |
Myb-DNA Binding/SANT Superfamily |
REB1 superfamily |
31.03% 5e-46 |
30.71% 4e-43 (NP_190575.1) |
42.31% 2e-39 (EHI_063550) |
|
EIN_080130 |
504 |
504 |
EiMyb9 |
23-114 |
Myb-DNA Binding/SANT Superfamily |
REB1 superfamily |
32.65% 4e-46 |
33.10% 1e-41 (NP_190575.1) |
38.40% 2e-40 (EHI_063550) |
|
EIN_276810* |
754 |
702 |
EiMyb10 |
31-124 |
Myb-DNA Binding/SANT Superfamily |
Transcription repressor MYB5; Provisional |
38.53% 4e-42 |
33.56% 6e-42 (NP_190575.1) |
31.48% 2e-38 (EHI_063550) |
|
III |
EIN_307410 |
507 |
507 |
EiMyb11 |
20-113 |
Myb-DNA Binding/SANT Superfamily |
Transcription repressor MYB5; Provisional |
30.58% 5e-46 |
31.72 7e-46 (VYS56784.1) |
47.47% 4e-39 (EHI_063550) |
EIN_307180 |
468 |
468 |
EiMyb12 |
19-113 |
Myb-DNA Binding/SANT Superfamily |
Transcription repressor MYB5; Provisional |
38.61% 5e-43 |
32.88% 5e-44 (NP_190575.1) |
40.27% 2e-41 (EHI_063550) |
|
EIN_308550 |
468 |
468 |
EiMyb13 |
19-112 |
Myb-DNA Binding/SANT Superfamily |
Transcription repressor MYB5; Provisional |
38.53% 1e-43 |
34.04% 4e-43 (NP_190575.1) |
40.29% 1e-40 (EHI_063550) |
|
- |
EIN_095310 |
474 | 474 |
EiMyb14 |
30-124 |
Myb-DNA Binding/SANT Superfamily |
PLN03091 super family hypothetical protein; Provisional |
37.07% 3e-40 |
33.87% 1e-40 (NP_195443.1) |
51.52% 2e-40 (EHI_153350 |
IV |
EIN_399710* |
1119 |
918 |
EiMyb15 |
161-255 |
Myb-DNA Binding/SANT Superfamily |
REB1 superfamily |
35.66% 2e-43 |
34.27% 2e-42 (NP_195443.1) |
68.29% 1e-48 (EHI_098070) |
EIN_490880 |
477 |
477 |
EiMyb16 |
41-140 |
Myb-DNA Binding/SANT Superfamily |
REB1 superfamily |
38.89% 2e-41 |
35.83% 1e-42 (NP_195443.1) |
39.09% 3e-39 (EHI_063550) |
|
EIN_310240 |
444 |
444 |
EiMyb17 |
31-125 |
Myb-DNA Binding/SANT Superfamily |
REB1 superfamily |
45.05% 4e-44 |
36.36% 3e-44 (NP_195443.1) |
44.25% 9e-40 (EHI_098070) |
|
EIN_425380 |
486 |
486 |
EiMyb18 |
32-124 |
Myb-DNA Binding/SANT Superfamily |
Transcription repressor MYB5; Provisional |
28.93% 1e-43 |
33.05% 6e-42 (OAO92063.1) |
44.14% 4e-35 (EHI_098070) |
|
EIN_046410 |
504 |
504 |
EiMyb19 |
39-132 |
Myb-DNA Binding/SANT Superfamily |
REB1 superfamily |
34.58% 2e-43 |
34.91% 1e-41 (OAO92063.1) |
51.25% 3e-47 (EHI_063550) |
|
V |
EIN_183110 |
456 |
456 |
EiMyb20 |
31-124 |
Myb-DNA Binding/SANT Superfamily |
PLN03091 super family hypothetical protein; Provisional |
33.07% 4e-46 |
37.01% 3e-46 (VYS56784.1) |
38.84% 1e-38 (EHI_098070) |
EIN_183730 |
459 |
459 |
EiMyb21 |
31-124 |
Myb-DNA Binding/SANT Superfamily |
PLN03091 super family hypothetical protein; Provisional |
38.10% 2e-42 |
33.08% 2e-42 (CAA0401764.1) |
64.10% 2e-39 (EHI_130060) |
|
EIN_169190 |
453 |
453 |
EiMyb22 |
15-108 |
Myb-DNA Binding/SANT Superfamily |
Transcription repressor MYB5; Provisional |
29.82% 2e-41 |
35.77% 2e-41 (AAS58517.1) |
46.48% 7e-39 (EHI_168310) |
|
EIN_359630 |
453 |
453 |
EiMyb23 |
29-122 |
Myb-DNA Binding/SANT Superfamily |
PLN03091 super family hypothetical protein; Provisional |
35.45% 4e-43 |
39.05% 2e-42 (CAA0383923.1) |
57.58% 4e-44 (EHI_129790) |
|
EIN_379820 |
453 |
453 |
EiMyb24 |
29-122 |
Myb-DNA Binding/SANT Superfamily |
PLN03091 super family hypothetical protein; Provisional |
34.43% 5e-44 |
32.41% 1e-43 (VYS56784.1) |
53.62% 5e-42 (EHI_129790) |
|
- |
EIN_168860 |
495 |
495 |
EiMyb25 |
29-126 |
Myb-DNA Binding/SANT Superfamily |
PLN03091 super family hypothetical protein; Provisional |
29.13% 9e-46 |
33.93% 3e-42 (CAD5329766.1) |
46.23% 1e-32 (EHI_092700) |
- |
EIN_405040 |
615 |
615 |
EiMyb26 |
65-458 |
Myb-DNA Binding/SANT Superfamily |
REB1 superfamily |
28.23% 4e-40 |
30.86% 1e-43 (AAS58517.1) |
43.37% 5e-36 (EHI_053000) |
- |
EIN_248780 |
714 |
714 |
EiCDC5-like |
10-102 |
CDC5L_II |
22.78% 5e-39 58.71% 8e-41 (CDC5) |
53.45% 2e-55 (OAP18307.1 CDC5) |
78.48% 2e-22 (EHI_000550) |
|
4R-MYBS | ||||||||||
SNAP-like |
EIN_267690 |
1992 | 1992 | EiSNAP-like I |
R1 436-599 |
SANT/Myb domain |
SANT/Myb domain |
28.22% 2e-11 39.08% 7e-08 (SNAP190) |
31.22% 3e-18 |
29.97% 1e-185 (EHI_130710) |
Motif consensus sequence | Modified sequence | Motif containing genes* |
E-value |
STREME confirmed |
Stage related genes |
[T/C]AAC[G/T]G |
CAACTG | 2559 (21.31%) | 2.0 e-036 | 2541 (99.29%) | Trophozoite |
DCAACTG | 815 (6.78%) | 1.3 e-011 | 807 (99.01%) | Encystation | |
CAACTG | 838 (6.97%) | 5.5 e-011 | 834 (99.52%) | Excystation | |
[CA]CCCCC |
MCCCCC | 288 (2.39%) | 1.1 e-007 | 284 (98.6%) | Trophozoite |
ACCCCCA | 99 (0.82%) | 6.8 e-003 | 97 (97.97%) | Encystation | |
CCCCCC | 100 (0.83%) | 1.8 e-001 | 98 (98.0%) | Excystation |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 MDPI (Basel, Switzerland) unless otherwise stated